Trial Comparing Relapse Rates Between Standard Ureteroscopic Removal Of Ureteral Stone And Standard Removal With Additional Ureterorenic Clearing Of Non-Symptomatic Stones In The Kidney
NCT ID: NCT02210650
Last Updated: 2022-05-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
75 participants
INTERVENTIONAL
2014-11-30
2022-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Asymptomatic Renal Calculi in Recurrent Urinary Tract Infections
NCT04495699
The Role of Ureteral Stenting Following Uncomplicated Ureteroscopy for Ureteral and Renal Stones: A Randomized, Controlled Trial
NCT03130907
Evaluation of Pain Before and After Removal of Non-obstructive Kidney Stones
NCT03657667
Primary Ureteroscopy for Acute Obstructive Nephropathy Due to Ureteral Stones: A Prospective Non-randomized Feasibility and Safety Trial
NCT07177313
Extracorporal Shockwave Lithotripsy Versus Retrograde Intrarenal Surgery for the Treatment of Kidney Stones
NCT01514032
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Symptomatic stone removal
Group 1 will receive the standard treatment of having only the symptomatic stone removed
Symptomatic stone removal
Symptomatic stone removal by the surgical procedures called Ureteroscopy or Percutaneous Nephrolithotomy
Asymptomatic kidney stones and symptomatic stone removed
Group 2 will include the step of having the asymptomatic kidney stones removed in addition to the symptomatic stone
Asymptomatic kidney stones and ureteral stone removed
Asymptomatic kidney stones and symptomatic stone removal by the surgical procedure called Ureteroscopy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Symptomatic stone removal
Symptomatic stone removal by the surgical procedures called Ureteroscopy or Percutaneous Nephrolithotomy
Asymptomatic kidney stones and ureteral stone removed
Asymptomatic kidney stones and symptomatic stone removal by the surgical procedure called Ureteroscopy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Computed tomography (CT) exam within the 90-day pre-operative period
* Small (≤ 6mm) asymptomatic stones in visible on KUB or CT (i.e., calcium stones) in the contralateral kidney for a primary renal stone or ipsilateral kidney for primary ureteral stone.
* Recurrent (having had previous stones) or multiple (simultaneous bilateral stones) stones
* Able to give informed consent
* Age 21 years or older
Exclusion Criteria
* Age less than 21 years
* Stones not visible on KUB or CT
* Patients with systemic disease or renal anatomical disorders (RTA, primary hyperparathyroidism, sarcoidosis, enteric hyperoxaluria, medullary sponge kidney)
* Any condition (eg, psychiatric illness) or situation that, in the investigator's opinion, could put the
* subject at significant risk, confound the study results, or interfere significantly with the subject's
* participation in the study.
* Unwilling to participate.
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Washington
OTHER
VA Puget Sound Health Care System
FED
Indiana Kidney Stone Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
James E Lingeman, MD
Role: PRINCIPAL_INVESTIGATOR
Indiana University Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Indiana University Health
Indianapolis, Indiana, United States
University of Minnesota
Minneapolis, Minnesota, United States
University of Washington Medical Center Department of Urology
Seattle, Washington, United States
Veterans Administration Puget Sound Heath Care System
Seattle, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Sorensen MD, Harper JD, Borofsky MS, Hameed TA, Smoot KJ, Burke BH, Levchak BJ, Williams JC Jr, Bailey MR, Liu Z, Lingeman JE. Removal of Small, Asymptomatic Kidney Stones and Incidence of Relapse. N Engl J Med. 2022 Aug 11;387(6):506-513. doi: 10.1056/NEJMoa2204253.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P01 DK 043881 Project 3
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.